Skip to main content
Premium Trial:

Request an Annual Quote

Lion Attributes Significant Jump in R&D to Ballooning Net Loss in Q3

NEW YORK, Feb. 6 - Lion Bioscience on Wednesday reported that a significant jump in R&D spending in the face of strong revenue growth in its fiscal third quarter caused the company to post a widened net loss.

 

For the three months ended Dec. 31, Lion reported total revenues of €10.3 million, or roughly $9 million, compared with €7.7 million in the year-ago period. The total was based on an increase in licensing fees to €5.9 million in the current quarter from €3 million one year ago, and a dip in R&D fees, which fell to €4.4 million this period from €4.7 million last year, the company reported.

 

A surge in R&D spending, which reached €12.9 million in the current third quarter compared with €8.5 million one year ago, pushed Lion to post €21 million in total expenditure for the quarter. By comparison, the company spent €12 million in the same period last year.

 

"This significant increase in R&D expense is primarily attributable to salaries as a result of hiring new personnel for our R&D activities, start-up costs for our pharmacophore informatics arrangement with Bayer, and product development activities surrounding projects with ... partners [like] IBM, Paradigm Genetics, and ACE Bioscience," Lion reported.

 

As a result, net loss in the third quarter of fiscal 2002 ballooned to €9.8 million, or €.52 per share, from €2.2 million, or €.15 per share, year over year.

 

Looking ahead, Lion said it expects R&D spending to increase "at a proportionally lower rate than revenues in order to enable us to generate a corresponding profit margin in the long term."

 

Shares in the German bioinformatics company were up $.82, or more than 7 percent, to $12 in mid-morning Nasdaq trading.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.